Levofloxacin can be used effectively as a positive control in thorough QT/QTc studies in healthy volunteers
about
Drug-induced QT interval prolongation: does ethnicity of the thorough QT study population matter?Analysis of Relationship between Levofloxacin and Corrected QT Prolongation Using a Clinical Data Warehouse.Editors' pick 2010.Comparison of the effects of levofloxacin on QT/QTc interval assessed in both healthy Japanese and Caucasian subjects (pagesUpdate on the cardiac safety of moxifloxacin.Insulin at normal physiological levels does not prolong QT(c) interval in thorough QT studies performed in healthy volunteersRepeated supratherapeutic dosing of strontium ranelate over 15 days does not prolong QT(c) interval in healthy volunteers.Cardiovascular and metabolic safety profiles of the fluoroquinolones.Antibiotic-induced cardiac arrhythmias.Novel targets and regulatory ordeal by QT interval.Macrolide and fluoroquinolone mediated cardiac arrhythmias: clinical considerations and comprehensive review.The Power of Phase I Studies to Detect Clinical Relevant QTc Prolongation: A Resampling Simulation Study.Levofloxacin-Induced QTc Prolongation Depends on the Time of Drug Administration.Prediction of the pharmacokinetics and tissue distribution of levofloxacin in humans based on an extrapolated PBPK model.A female patient with hypokalaemia-induced J wave syndrome: An unusual case report.QT/QTc study conducted in Japanese adult healthy subjects: a novel xanthine oxidase inhibitor topiroxostat was not associated with QT prolongation.
P2860
Q27006580-91341A63-FA76-4E3A-8CD3-C1BACD18C33EQ33983552-A794C479-DD3F-4956-AB27-B8156F5471A1Q34476042-119E94ED-0E90-4DEF-9034-64C5E97B72E1Q36017405-6BBC0852-F54E-4B17-9680-DDA9C8FA4BE7Q36345861-B81F06AE-6CBC-42BE-A1FE-28FCC4894CF9Q36629217-FC53ED9B-F630-4F8B-88D9-BA7AA03F1158Q36779127-3EC55775-DA21-40E8-9A53-A9D0A897B6A8Q37940543-202D3C22-1EA6-4321-B472-9211F894531EQ38178757-DE25E344-84EE-4D3D-AA46-6B8FB89768F6Q39871284-1428B2F4-0E17-4910-8189-D736F72B2C57Q40108685-3D55C4FF-9B3D-463D-9979-A9DA86865137Q40384625-68EEF92A-6AC0-4421-A009-7B709BD95386Q41181891-5EC64371-EA94-4BCC-A807-C448B12F0BA3Q41262080-2D25EC53-C8B5-40F3-978E-474BCBB1E7AEQ42365443-12BE22B3-230D-49FE-9D78-CD8EC09E7C34Q48915041-E8865D15-4E4C-45DE-ADA0-D876C220385E
P2860
Levofloxacin can be used effectively as a positive control in thorough QT/QTc studies in healthy volunteers
description
2010 nî lūn-bûn
@nan
2010 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Levofloxacin can be used effec ...... studies in healthy volunteers
@ast
Levofloxacin can be used effec ...... studies in healthy volunteers
@en
Levofloxacin can be used effec ...... studies in healthy volunteers
@nl
type
label
Levofloxacin can be used effec ...... studies in healthy volunteers
@ast
Levofloxacin can be used effec ...... studies in healthy volunteers
@en
Levofloxacin can be used effec ...... studies in healthy volunteers
@nl
prefLabel
Levofloxacin can be used effec ...... studies in healthy volunteers
@ast
Levofloxacin can be used effec ...... studies in healthy volunteers
@en
Levofloxacin can be used effec ...... studies in healthy volunteers
@nl
P2093
P2860
P3181
P1476
Levofloxacin can be used effec ...... studies in healthy volunteers
@en
P2093
A John Camm
Asif Naseem
Duolao Wang
Jorg Taubel
Radivoj Arezina
Tomohiko Harada
Ulrike Lorch
P2860
P304
P3181
P356
10.1111/J.1365-2125.2009.03595.X
P407
P577
2010-04-01T00:00:00Z